Dashboard
Manage Tickers

ATHA Athira Pharma, Inc.

Nasdaq athira.com


$ 3.70 $ -0.05 (-1.35 %)    

Thursday, 16-Oct-2025 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 3.66
$ 3.74
$ 3.53 x 300
$ 3.95 x 200
$ 3.60 - $ 3.88
$ 2.20 - $ 8.26
22,306
na
14.43M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

athira-pharma-has-been-granted-a-us-patent-methods-of-treating-neurodegenerative-disease-including-dementia-alzheimers-disease-and-parkinsons-disease-with-substituted-n-hexanoic-l-tyrosine-l-isoleucine-6-aminohexanoic-amide-analogues-httpstconshlvnfwcm
Athira Pharma Has Been Granted A U.S. Pate...
09/23/2025 20:00:38

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12421276).pn

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/18/2025 12:55:07

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/17/2025 23:50:04

athira-pharma-to-implement-10-for-1-reverse-stock-split-following-shareholder-approval-at-may-2025-annual-meeting
Athira Pharma To Implement 10-For-1 Revers...
09/11/2025 13:03:51

Athira Pharma, Inc. ("Athira" or "Company") (NASDAQ:ATHA), a clinical stage biopharmaceutical company focused o...

athira-pharma-presents-phase-1-results-for-ath-1105-in-healthy-volunteers-at-als-nexus-2025-supporting-continued-als-development
Athira Pharma Presents Phase 1 Results For...
08/14/2025 11:11:48

athira-pharma-q2-eps-018-inline
Athira Pharma Q2 EPS $(0.18), Inline
08/07/2025 20:55:55

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/16/2025 21:06:00

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/09/2025 21:06:01

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
06/05/2025 12:08:31

athira-pharma-to-present-data-from-phase-1-clinical-trial-of-ath-1105-in-healthy-volunteers-at-4th-annual-als-drug-development-summit
Athira Pharma To Present Data From Phase 1...
05/13/2025 15:02:22

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose pro...

athira-pharma-q1-eps-023-up-from-069-yoy
Athira Pharma Q1 EPS $(0.23) Up From $(0.6...
05/09/2025 20:08:51

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.23) per share. This is a 66.67 percent increase over losses of $(0...

athira-pharma-fy-2024-gaap-eps-252-beats-254-estimate
Athira Pharma FY 2024 GAAP EPS $(2.52) Bea...
02/27/2025 21:43:06

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(2.52) per share which beat the analyst consensus estimate of $(2.54)...

athira-pharma-presents-preclinical-data-highlighting-neuroprotective-effects-of-ath-1105-in-models-of-als-at-motor-neurone-disease-associations-international-symposium-on-alsmnd
Athira Pharma Presents Preclinical Data Hi...
12/07/2024 00:14:47

Athira Pharma, Inc. (NASDAQ:ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore ...

athira-pharma-q3-eps-075-misses-069-estimate
Athira Pharma Q3 EPS $(0.75) Misses $(0.69...
11/07/2024 22:18:33

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.6...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/05/2024 16:34:40

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
11/01/2024 16:36:54

why-charter-communications-shares-are-trading-higher-by-around-11-here-are-20-stocks-moving-premarket
Why Charter Communications Shares Are Trad...
11/01/2024 13:15:35

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/01/2024 12:11:51

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/01/2024 12:11:51

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
10/31/2024 20:34:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION